MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 99 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,130,000 | +55.2% | 1,175,000 | +27.0% | 0.28% | +127.3% |
| Q2 2023 | $23,929,750 | +7.1% | 925,000 | -0.5% | 0.12% | -16.6% |
| Q1 2023 | $22,336,366 | +34.0% | 929,907 | +8.8% | 0.14% | +9.0% |
| Q4 2022 | $16,670,687 | -32.8% | 854,907 | -27.5% | 0.13% | -15.8% |
| Q3 2022 | $24,790,000 | +5.1% | 1,179,907 | -2.7% | 0.16% | +13.7% |
| Q2 2022 | $23,594,000 | +10.0% | 1,212,432 | +24.5% | 0.14% | +43.3% |
| Q1 2022 | $21,441,000 | – | 973,709 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |